ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Plaintiffs’ Co-Lead Counsel Announce Four Major Settlements with Juul Labs, Inc. Addressing U.S. Youth E-Cigarette Usage

The four settlements with Juul Labs announced today resolve the personal injury, consumer class action, government entity, and tribal harm cases brought in the national MDL and the JCCP in California

Co-Lead Counsel for Plaintiffs in the federal multidistrict litigation captioned In re: Juul Labs, Inc., Marketing, Sales Practices and Products Liability Litigation, MDL No. 2913, and the coordinated proceeding captioned Juul Labs Product Cases, JCCP No. 5052, today announce four separate global settlements with Juul Labs, Inc. Together, these settlements will help address youth use of e-cigarettes.

The settlements follow three-plus years of hard-fought litigation in both state and federal court. Co-Lead Counsel believe that resolving the litigation against Juul Labs and its officers and directors through settlement is in the best interests of all plaintiffs. The settlements build on Juul’s recent settlements with states and territories. These settlements provided monetary relief to states and territories and required changes to Juul’s marketing and other practices, including prohibitions on youth marketing and the sale of flavors not authorized by the FDA, but did not provide direct compensation to anyone. The four settlements announced today provide needed relief for individuals, local government entities, and Native American tribes.

The four settlements resolve the personal injury, consumer class action, government entity, and tribal cases brought in the MDL and the JCCP.

  • The personal injury settlement will provide meaningful compensation to people suffering from nicotine addiction and other injuries.
  • The consumer class action settlement will remunerate consumers who purchased JUUL products.
  • The government entity settlement will provide resources to school districts, cities, and counties to abate youth nicotine addiction in their communities; and
  • The tribal settlement will provide similar much-needed funding for Native American tribes.

The Juul settlements include over 8,500 personal injury cases, over 1,400 government entity cases, and 34 tribal cases. “The scope of these suits is enormous,” notes Lieff Cabraser partner Sarah R. London, who serves as Co-Lead Counsel for MDL Plaintiffs in the litigation. “These settlements will put meaningful compensation in hands of victims and their families, get real funds to schools for abatement programs, and help government and tribal entities prevent youth use of e-cigarettes across the U.S.”

The Juul settlements do not release claims against Altria Group, Inc., or its related companies that are also defendants in the federal or state litigation. Co-Lead Counsel remain committed to continuing the litigation against Altria, including in the San Francisco Unified School District bellwether trial scheduled for April 2023 in the federal MDL.

Next Steps

The Court will hold a hearing in the near future to review the proposed class settlement. If the settlement receives preliminary approval, a Class Settlement Administrator will be appointed to structure and initiate a formal claims process. At that time, the Class Settlement Administrator will notify class members about their rights under the Settlement. Meanwhile, a claims process will begin for the Personal Injury, Government Entity, and Tribal settlements.

The four settlements with Juul Labs announced today resolve the personal injury, consumer class action, government entity, and tribal harm cases brought in the national MDL and the JCCP in California

Contacts

Sarah London

LIEFF CABRASER HEIMANN & BERNSTEIN, LLP

275 Battery Street, Fl. 29

San Francisco, CA 94111

Telephone: (415) 956-1000

Dena Sharp

GIRARD SHARP LLP

601 California St., Suite 1400

San Francisco, CA 94108

Telephone: (415) 981-4800

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.